Since the beginning of the AIDS epidemic, it has been obviThe purpose of this article is to review the causes of diarrhea in HIV-infected individuals, review the information concerning ous that diarrhea is one of the most common manifestations of this infection. In Africa, HIV infection has been characterized the impact of highly active antiretroviral therapy (HAART) on this clinical manifestation, and, because data on the role of by a relentlessly progressive condition called Slims disease, which is the result of unremitting watery diarrhea, weight loss, HAART in causing diarrhea are only just becoming available, to speculate about the future impact of HAART on diarrheal severe malnutrition, low-grade fever with night sweats, and, finally, a wasting away followed by death. Although multiple illness in HIV-infected patients. parasites, pathogenic bacteria, and, occasionally, viruses have been isolated from the stool of up to two-thirds of patients with AIDS, pathogen-specific therapy has generally been only
Causes of Diarrhea in HIV-Infected Patients minimally effective and diarrhea generally considered a maniBacteria festation of the underlying immunodeficiency.
Diarrhea has been described previously in association with Pathogen-specific therapy is often successful in cases where various other immunodeficiency syndromes; up to 60% of papathogenic bacteria are identified. Such cases include infections tients with common variable hypogammaglobulinemia have due to Shigella, Salmonella, and Campylobacter species for diarrhea, with 40% developing malnutrition [1, 2] . In the case which treatment with the fluoroquinolones usually resolves the of severe combined immunodeficiency, patients are extremely diarrhea and fever. However, relapses after discontinuation of prone to infections and they commonly succumb to chronic therapy have been observed more frequently among HIV-indiarrhea and malabsorption. In selective IgA deficiency -the fected individuals than in the general population. A curious most common immunodeficiency state in humans that affects syndrome of nontyphoidal salmonella bacteremia that repeat-1 of 500 -3,000 people in the general population -recurrent edly relapses when effective therapy is discontinued has been bronchosinusopulmonary infections are often associated with reported, a phenomenon observed in other opportunistic infeca high incidence of gastrointestinal disease, including diarrhea, tions such as cryptococcal meningitis and disseminated histosteatorrhea, and celiac sprue.
plasmosis [3] . Campylobacter upsaliensis has recently been In the Western world, diarrhea has also dominated the cliniidentified as a cause of chronic diarrhea in Australia [4] . cal picture of patients with advanced HIV and, in fact, has Diarrhea associated with Clostridium difficile can be a particbeen a clinical indicator of progression of immunodeficiency ularly difficult diagnostic dilemma in patients with AIDS, given along with thrush, weight loss, fevers, and night sweats. In that they are often taking various types of antibiotics and bemany cases pathogenic organisms could be isolated, and varicause diarrhea is so common among these patients. A C. diffious algorithms were developed to standardize the work-up of cile -toxin assay should always be part of a work-up for newthis condition. However, not all cases of chronic diarrhea in onset watery diarrhea, with or without fecal leukocytes, espeadvanced AIDS can be attributed to an infectious etiology, cially if the diarrhea is associated with fever, leukocytosis, and thus the therapeutic approach is limited. Drug side effects, cramps. Treatment with metronidazole, 250 mg po t.i.d. for 7 gastrointestinal malignancies (Kaposi's sarcoma, lymphoma), to 10 days, is usually curative. However, as in the general and HIV enteropathy are often listed as likely causes.
population, up to 20% of patients will have a relapse, and these relapses should be retreated with metronidazole at the same dosage. The annual incidence of C. difficile -associated diar-patients who had CD4 cell counts of õ50/mm 3 [6] . Others epidemic. The most notorious of these is Cryptosporidium parvum. This organism was a recognized pathogen in cattle and have found no difference in prevalence of EaggEc in HIVpositive patients with and without diarrhea [7] . EaggEc have hogs and had been associated with small outbreaks of cryptosporidiosis in veterinarians and others before 1980. Since then, been associated with persistent diarrhea in children in developing countries. The pathophysiologic mechanism by which multiple outbreaks have been reported and the organism has been shown to be highly infectious (as few as 132 oocysts can this organism causes diarrhea is not entirely clear. It is known that a heat-stable toxin that appears to mediate secretion cause diarrhea in a normal adult) [10] .
In patients with advanced AIDS, usually with CD4 cell through cyclic guanosine monophosphate (GMP) is produced. In addition, some strains produce a larger toxin that stimulates counts of õ150/mm 3 , C. parvum produces a large-volume watery diarrhea that is usually progressive but is occasionally IL-8, and other strains have the ability to invade enterocytes directly.
associated with spontaneous remissions and reexacerbations that last for years. In HIV-infected patients with CD4 cell Studying the epidemiology of EaggEc has been challenging, mainly because it is difficult to recover the organisms from counts of ú180/mm 3 , the diarrhea resolved spontaneously in 7 to 28 days, but the diarrhea persisted in 87% of those with stool. These organisms cannot be identified by use of routine stool culture; the expensive tissue culture adherence assay is CD4 cell counts of õ180/mm 3 [11] . HAART is protective against disease [12] . C. parvum is easily identified in stool with required (all strains aggregate in HeLa or HEp-2 tissue culture assays). This assay remains the most reliable tool for identificause of a modified acid-fast stain and is seen attached to the brush borders on the external surface of the small intestinal tion of the organisms. The true prevalence of EaggEc in the stool of nonimmunocompromised adults around the world is epithelium. Pathogen-specific therapy for cryptosporidiosis has been disnot known. In a small study of non-HIV-infected adults with diarrhea, EaggEc was identified in 19 (28%) of 68 patients [6] .
appointing. Initially, in a small study that lacked controls, azithromycin was found to be effective, however, when tested In the same study, HIV-positive individuals with and without diarrhea were screened for evidence of EaggEc in the stool.
in a larger controlled study, it was no better than placebo. Paromomycin, a nonabsorbable aminoglycoside, was also The organisms were identified in the stool of individuals in both groups, although more frequently in the patients with touted as effective, but no benefit was reported in a prospective double-blind randomized study [13] . Roxithromycin, a new diarrhea. The CD4 cell counts were lower in the diarrheal group (mean, 94/mm 3 vs. 157/mm 3 ), suggesting that these organisms macrolide studied in Brazil, has also demonstrated efficacy in an uncontrolled study [14] . More recently, a powdered immuare more likely to produce diarrhea when immunosuppression is more advanced.
noglobulin concentrate from bovine colostrium demonstrated a modest response [15] . A second approach that was tried as Quinolone therapy for infections due to EaggEc may be beneficial, and resistance of these organisms to ciprofloxacin therapy for cryptosporidiosis was inhibition of the normal-gut secretory mechanisms with octreotide (Sandostatin, Sandoz remains low. In a recent placebo-controlled cross-over treatment trial, therapy with ciprofloxacin, 500 mg po b.i.d. for 7 Pharma, Basel, Switzerland), an inhibitor of somatostatin, a gut hormone. These studies proved that octreotide reduced the days, resulted in a 50% reduction in the number of stools per day and a 40% decrease in intestinal symptoms, as well as total volume of stool produced when a patient was infected with cryptosporidia by one-third to one-half in some patients, elimination of EaggEc from the stool in all 24 patients [8] .
In a recent study from Switzerland, small bowel bacterial but had little effect in most [16] . The therapy is extremely expensive and has never been adopted as a standard of care. overgrowth (SBBO) was present in 19% of HIV-infected patients with chronic, pathogen-negative diarrhea [9] . SBBO was
The most effective therapy for cryptosporidiosis is HAART. Immune reconstitution following potent antiretroviral therapy defined as §10 5 cfu of bacteria per gram of aspirate, as determined by quantitative culture of small bowel fluid aspirates can induce diarrheal cessation, weight gain, and complete remission of cryptosporidiosis. In most patients with persistent (endoscopy was extended to the jejunum by use of a pediatric colonoscope). The most common organisms isolated were viricryptosporidial diarrhea who were treated with HAART, the symptoms disappeared once they had CD4 cell count increases dans streptococci, Lactobacillus species, yeast, and Neisseria pharyngitides. No gram-negative organisms or anaerobes were to ú250/mm 3 , and the organism could not be found by stool microscopy or in biopsy samples. However, clinical relapses isolated. No data are currently available to determine whether the eradication of SBBO affects the outcome of pathogenwere documented when HAART failed, CD4 cell counts fell, and HIV-1 RNA levels increased, suggesting that the infection negative diarrhea in HIV-infected patients.
was not eradicated [17 -19] .
Another previously unusual gut pathogen, Isospora belli, Parasites also emerged as a significant cause of diarrhea in patients with advanced AIDS. It produces a clinical syndrome similar to The most common pathogens isolated from patients with AIDS continue to be new and unusual parasitic organisms that cryptosporidiosis that usually occurs in patients with CD4 cell counts of õ100/mm Mycobacterium avium complex (MAC) is a common infecThe distinction is important because Isospora species usually tious agent in patients with AIDS, especially when the CD4 respond to therapy with trimethoprim-sulfamethoxazole (TMPcell count decreases to õ50/mm 3 . The most common presenta-SMZ); one double-strength tablet po q.i.d. for 10 days followed tion is a febrile illness with weight loss, anorexia, night sweats, by b.i.d. for 3 weeks, and then chronic suppression with one and a generalized catabolic state. Cultures of blood are positive, tablet 3 times a week for the duration of immunosuppression). and patients will usually respond to therapy with a macrolide Without chronic suppression, relapses are common. The numand ethambutol, but suppressive therapy is necessary to prevent ber of patients reported to date is not adequate to determine relapse. Diarrhea is common in these patients, and a biopsy of with certainty whether suppression can be stopped with TMPthe small bowel may show macrophages filled with acid-fast SMZ, but it most likely can be discontinued if the response of bacilli, similar to Whipple's disease. The diarrhea is usually the CD4 cell count to this therapy is robust (ú250/mm 3 ).
watery, without fecal WBCs, and may be associated with malThe various microsporidia, which include Encephalitozoon absorption and diffuse abdominal cramping in the late stages intestinalis (Septata intestinalis), Enterocytozoon bieneusi, and of disease. Whether the diarrhea consistently responds to antiEncephalitozoon hellem are food-borne and water-borne spores mycobacterial therapy is not clear from published reports. Alof 1-2 mm that can be seen in stool with Giemsa or special though it is not yet an established standard of care, many trichrome stains [20] . They account for up to 20% of diarrheal clinicians are discontinuing suppressive anti-MAC therapy disease in patients with CD4 cell counts of õ50/mm 3 and when a robust CD4 cell count response (ú250/mm 3 ) follows as much as 60% in patients with chronic diarrhea [21] . The HAART. pathophysiologic mechanism by which microsporidia cause diMycobacterium tuberculosis should also be included in the arrhea is not entirely clear. It appears in part to be malabsorpdifferential diagnosis for patients from areas with high tubercutive, caused by a reduction of absorptive mucosal surface area losis prevalence [26] . and enterocyte immaturity with impairment of function [22] .
The clinical syndrome cannot be distinguished from that caused by Cryptosporidium or Isospora species: a large-volume Viruses watery diarrhea without WBCs, with malabsorption and wasting that is remittent over years. There is no standard treatment
Although various viruses such as rotavirus, adenovirus, coronavirus, astrovirus, and calicivirus (as defined by electron-mifor microsporidiosis, although case reports and small case series have indicated that metronidazole (500 mg b.i.d.) decreased croscopy of stool specimens) have been implicated as causes of diarrhea in patients with AIDS, most infections appear to diarrhea in 10 of 19 patients but did not clear the organism from the stool in any of the patients. Albendazole, 400 mg po be self-limited and are untreatable [27] . In Argentina, a picobirnavirus was recently detected in 9% of HIV-infected individub.i.d., rapidly controlled diarrhea due to E. bieneusi and E. intestinalis in 3 of 10 patients, but 4 had no response [23] ; als with chronic diarrhea but not in HIV-infected patients without diarrhea or in non-HIV-infected patients with diarrhea [28] . atovaquone, 750 mg t.i.d., decreased diarrhea in 8 of 8 patients but did not eradicate the organism from the stool [24] . For Cytomegalovirus, however, accounts for up to 20% of diarrhea in patients with AIDS and is potentially treatable. This virus E. hellem, single case reports indicate that therapy with albendazole, itraconazole, or fluconazole has been somewhat suctypically produces a colitis that colonoscopy reveals as punctuate hemorrhages with ulcerations, which demonstrate typical cessful. With HAART, E. bieneusi was cleared from the stools in two of six patients after 24 weeks [25] . In another study, intranuclear inclusions on biopsy. In 10% to 30% of cases, the virus will affect only the right side ascending colon and be complete remission of diarrhea due to E. bieneusi occurred with HAART [17] . In these patients, the need for chronic supmissed on sigmoidoscopy [29] . The clinical picture is typically one of fever and small-volume, occasionally bloody diarrhea pression should disappear, but more conclusive studies are needed before we can do more than speculate.
with fecal leukocytes, occasionally leading to perforation or toxic megacolon. Treatment is with either ganciclovir or foscarOther pathogenic parasites that are more common in the general population such as Entamoeba histolytica, Giardia, and net in similar dosages as those used to treat CMV retinitis. Some patients definitely respond to anti-CMV therapy, but Cyclospora species can also cause diarrhea in patients with AIDS and should be considered in the differential diagnosis.
overall response rates are generally not as good as those for retinitis [30] . Cyclospora cayetanensis usually occurs in patients with CD4 cell counts of õ100/mm 3 ; these patients will usually respond Suppressive therapy is critical, but when there is a rise in CD4 cell counts (ú250/mm 3 ) with HAART, many clinicians in 2 -3 days to therapy with TMP-SMZ, one double-strength tablet b.i.d. for 10 days, then one tablet three times a week for are starting to discontinue either the ganciclovir or foscarnet therapy for CMV retinitis and wait for symptoms to reappear the duration of immunosuppression. For patients treated with HAART whose CD4 cell counts increase to ú250/mm 3 , one [31, 32] . Because therapy is expensive, toxic, and difficult to administer intravenously, this approach certainly makes sense, would be tempted to discontinue suppression.
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03-15-99 08:19:52 cida UC: CID although one may be forced to reinstitute induction therapy if because of the introduction of HAART. However, diarrhea will likely remain one of the most troublesome clinical manifestarelapse occurs. To date there are just no convincing data to guide recommendations.
tions of HIV infection and will now most likely reflect toxicity from the various antiretroviral drugs used to treat the underlying HIV infection and restore the damaged immune system.
When No Pathogen Can Be Identified
In 15% to 46% of HIV-infected patients with diarrhea, no pathogen can be identified and HIV itself may be important in one study to have some benefit in reducing diarrhea in these 4. Jenkin GA, Tee W. Campylobacter upsaliensis -associated diarrhea in patients [34] . series had diarrhea [40] . 
